These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

32 related articles for article (PubMed ID: 9820384)

  • 1. Sigmoidoscopic extent of ulcerative colitis and associated factors in Pakistani population.
    Saleem A; Zeeshan M; Hazoor F; Mustafa G
    Pak J Med Sci; 2022; 38(1):276-280. PubMed ID: 35035439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Sigmoidoscopic examinations on 483 cases with symptoms].
    CHOI TS; TOH SH; CHUNG KS
    Taehan Naekwa Hakhoe Chapchi; 1962 Mar; 5():195-203. PubMed ID: 13879129
    [No Abstract]   [Full Text] [Related]  

  • 3. Patient self-reported symptoms using visual analog scales are useful to estimate endoscopic activity in ulcerative colitis.
    Tsuda S; Kunisaki R; Kato J; Murakami M; Nishio M; Ogashiwa T; Yoshida T; Kimura H; Kitano M
    Intest Res; 2018 Oct; 16(4):579-587. PubMed ID: 30301332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Activity and Quality of Life Indices Are Valid Across Ulcerative Colitis But Not Crohn's Disease Phenotypes.
    Taleban S; Stewart KO; Li DK; Singh P; Pardi DS; Sturgeon HC; Yajnik V; Xavier RJ; Ananthakrishnan AN; Khalili H
    Dig Dis Sci; 2016 Sep; 61(9):2627-35. PubMed ID: 27142671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contribution of susceptibility variants at FCGR2A and 13q12 to the risk of relapse among Japanese patients with ulcerative colitis.
    Asano K; Esaki M; Umeno J; Hirano A; Maehata Y; Moriyama T; Nakamura S; Matsumoto T; Kitazono T
    J Gastroenterol; 2015 Nov; 50(11):1094-102. PubMed ID: 25787843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osteopontin as two-sided mediator of intestinal inflammation.
    Heilmann K; Hoffmann U; Witte E; Loddenkemper C; Sina C; Schreiber S; Hayford C; Holzlöhner P; Wolk K; Tchatchou E; Moos V; Zeitz M; Sabat R; Günthert U; Wittig BM
    J Cell Mol Med; 2009 Jun; 13(6):1162-74. PubMed ID: 18627421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcome measurement in clinical trials for Ulcerative Colitis: towards standardisation.
    Cooney RM; Warren BF; Altman DG; Abreu MT; Travis SP
    Trials; 2007 Jun; 8():17. PubMed ID: 17592647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increases in free radicals and cytoskeletal protein oxidation and nitration in the colon of patients with inflammatory bowel disease.
    Keshavarzian A; Banan A; Farhadi A; Komanduri S; Mutlu E; Zhang Y; Fields JZ
    Gut; 2003 May; 52(5):720-8. PubMed ID: 12692059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inflammatory bowel diseases: controversies in the use of diagnostic procedures.
    Vucelic B
    Dig Dis; 2009; 27(3):269-77. PubMed ID: 19786751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medical management of ulcerative proctitis, proctosigmoiditis, and left-sided colitis.
    Bitton A
    Semin Gastrointest Dis; 2001 Oct; 12(4):263-74. PubMed ID: 11726080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation between endoscopic severity and the clinical activity index in ulcerative colitis.
    Seo M; Okada M; Maeda K; Oh K
    Am J Gastroenterol; 1998 Nov; 93(11):2124-9. PubMed ID: 9820384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An index of disease activity in patients with ulcerative colitis.
    Seo M; Okada M; Yao T; Ueki M; Arima S; Okumura M
    Am J Gastroenterol; 1992 Aug; 87(8):971-6. PubMed ID: 1642220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of disease activity in patients with moderately active ulcerative colitis: comparisons between a new activity index and Truelove and Witts' classification.
    Seo M; Okada M; Yao T; Okabe N; Maeda K; Oh K
    Am J Gastroenterol; 1995 Oct; 90(10):1759-63. PubMed ID: 7572889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlations among total colonoscopic findings, clinical symptoms, and laboratory markers in ulcerative colitis.
    Osada T; Ohkusa T; Okayasu I; Yoshida T; Hirai S; Beppu K; Shibuya T; Sakamoto N; Kobayashi O; Nagahara A; Terai T; Watanabe S
    J Gastroenterol Hepatol; 2008 Dec; 23 Suppl 2():S262-7. PubMed ID: 19120909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of serum biomarkers with clinical severity and mucosal inflammation in Chinese ulcerative colitis patients.
    Lok KH; Ng CH; Hung HG; Li KF; Li KK; Szeto ML
    J Dig Dis; 2008 Nov; 9(4):219-24. PubMed ID: 18959594
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.